treat rheumatoid arthritis, cryopyrin-associated periodic syndromes, familial Mediterranean... [1][2][5] It is administered subcutaneously to patients diagnosed with a cryopyrin-associated...
See how 30259 people just like you are living with rheumatoid arthritis. Learn from their data and experience.
Researchers assessed cognitive function among rheumatoid arthritis patients with ongoing inflammatory activity.
Rheumatoid Patient Foundation | LinkedIn 팔로워 307명 | The Rheumatoid Patient Foundation (RPF) is dedicated to improving the lives of people with Rheumatoid diseases such as Rheumatoid Arthritis (RA)...
Abstract 10.1002/art.11257.abs Objective To assess the safety of tacrolimus used in combination with oral methotrexate (MTX) to control the signs and symptoms of rheumatoid arthritis (RA) in patien...
Rheumatoid arthritis is a chronic inflammatory joint disease, which can cause cartilage and bone damage as well as disability. Early diagnosis is key to optimal therapeutic success, particularly in...
Information for patients and caregivers on rheumatoid arthritis (RA): what it is, causes, getting diagnosed, treatment options, and tips for living with RA.
Patients with rheumatoid arthritis (RA) and other inflammatory joint disorders (IJD) have increased cardiovascular disease (CVD) risk compared with the general population. In 2009, the European Lea...
Astellas Pharma’s Smyraf (ingredient: peficitinib) obtained regulatory approval for the treatment of rheumatoid arthritis. Smyraf is the third oral Janus kinase (JAK) inhibitor to receive approval...
In patients with rheumatoid arthritis and an inadequate response to biologic DMARDs, baricitinib at a daily dose of 4 mg was associated with clinical improvement at 12 weeks. (Funded by Eli Lilly a...